Conclusions: The CCRB technique is a simple, effective, minimally invasive outpatient treatment with few complications. Only one patient required additional treatment for bleeding. Objectives: Measurements of serum hormones are used to indicate the likely location and viability of a pregnancy when it cannot be visualised with ultrasound and in some cases decide on Methotrexate treatment. We aimed to define the performance of single measurements of serum hCG, progesterone and the hCG ratio (hCG 48hrs/hCG 0hrs) for diagnosing pregnancy viability and location. Methods: This was a prospective multi-centre cohort study of 3272 women with a PUL. Eight patients met exclusion criteria, 367 had initial hCG ≤25 IU/L and 297 were lost to follow-up, leaving 2600 for analysis. Serum hCG and progesterone were measured at presentation and hCG again at 48 hours. The final outcome of the pregnancy was classified into three groups: (1) viable IUP (VIUP), (2) non-viable IUP (NVIUP) or failed PUL and (3) ectopic pregnancy (EP) or persisting PUL. We defined the probability of each category across a range of values for single hCG, single progesterone and hCG ratio likely to be encountered in clinical practice and tested their performance in predicting viability and pregnancy location. All analyses were based on available data. Results: We found 19.6% VIUP when single hCG >1000 IU/L, 14.4% when single hCG >2000 IU/L and 11.4% when single hCG >3000 IU/L. No single hCG cut-off excludes an EP. We observed 1.4% VIUP when hCG ratio <1.5. When single progesterone was <10nmol/l, 7.5% PUL were EP and 0.1% were VIUP. Conclusions: Commonly used cut-off values for hCG ratio and progesterone used to define non-viability (hCG >3000 IU/L, hCG ratio <1.5, progesterone <10 nmol/l) may be associated with a viable intrauterine pregnancy. Similarly, single measurements of hCG used to define the likely presence or absence of an EP or VIUP are not specific and should not be used in clinical practice.
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Evaluating cut-off values for progesterone, single hCG and hCG ratio to define pregnancy viability and location in women with a pregnancy of unknown location (PUL) Objectives: Measurements of serum hormones are used to indicate the likely location and viability of a pregnancy when it cannot be visualised with ultrasound and in some cases decide on Methotrexate treatment. We aimed to define the performance of single measurements of serum hCG, progesterone and the hCG ratio (hCG 48hrs/hCG 0hrs) for diagnosing pregnancy viability and location. Methods: This was a prospective multi-centre cohort study of 3272 women with a PUL. Eight patients met exclusion criteria, 367 had initial hCG ≤25 IU/L and 297 were lost to follow-up, leaving 2600 for analysis. Serum hCG and progesterone were measured at presentation and hCG again at 48 hours. The final outcome of the pregnancy was classified into three groups: (1) viable IUP (VIUP), (2) non-viable IUP (NVIUP) or failed PUL and (3) ectopic pregnancy (EP) or persisting PUL. We defined the probability of each category across a range of values for single hCG, single progesterone and hCG ratio likely to be encountered in clinical practice and tested their performance in predicting viability and pregnancy location. All analyses were based on available data. Results: We found 19.6% VIUP when single hCG >1000 IU/L, 14.4% when single hCG >2000 IU/L and 11.4% when single hCG >3000 IU/L. No single hCG cut-off excludes an EP. We observed 1.4% VIUP when hCG ratio <1.5. When single progesterone was <10nmol/l, 7.5% PUL were EP and 0.1% were VIUP. Conclusions: Commonly used cut-off values for hCG ratio and progesterone used to define non-viability (hCG >3000 IU/L, hCG ratio <1.5, progesterone <10 nmol/l) may be associated with a viable intrauterine pregnancy. Similarly, single measurements of hCG used to define the likely presence or absence of an EP or VIUP are not specific and should not be used in clinical practice.
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Objectives: To examine the accuracy of transvaginal ultrasound in detecting the presence of hemoperitoneum in tubal ectopic pregnancy and the correlation between severity of hemoperitoneum on ultrasound and volume of hemoperitoneum at surgery. Methods: This was a prospective study of women diagnosed with a tubal ectopic pregnancy who were managed in the Early Pregnancy Unit (EPU) at University College London Hospital (UCLH) between November 2015 and August 2016.
During the study period, we categorised hemoperitoneum semi-quantitatively as mild when there was echogenic fluid present in the pouch of Douglas, moderate when there were visible blood clots and severe when there were blood clots and echogenic fluid present both in the pouch of Douglas and in the uterovesical space.
The operating surgeons were blinded to the semi-quantitative assessment for the purpose of the study. They were asked to estimate subjectively the volume of hemoperitoneum immediately after insertion of the laparoscope with the patient lying supine. They were also asked to take into account the amount of blood aspirated form the pelvis during surgery to assist with their estimate. Results: A total of 105 women were diagnosed with a tubal ectopic pregnancy on ultrasound examination out of which 32/105 (30.5%) had evidence of hemoperitoneum on scan.
71 cases were managed surgically during the study period and 52/71 (73.2%) had evidence of hemoperitoneum at surgery. Transvaginal sonography had a sensitivity of 59.6% and a specificity of 100% in diagnosing hemoperitoneum. The median volume of hemoperitoneum at surgery was 100ml in the mild group and 400ml in the moderate and severe group. The degree of hemoperitoneum on ultrasound was significantly associated with the volume of hemoperitoneum at surgery, with the p-value being less than 0.001.
Conclusions:
The degree of hemoperitoneum on ultrasound correlates strongly with the volume of hemoperitoneum at surgery. All women with evidence of moderate or severe hemoperitoneum should be offered emergency surgery without delay.
